Impact of p53 T253I on expression of DNA damage responsive proteins. by Nathaniel C. Holcomb (22793595)

WHODAS Outcomes (ITT Analysis). by Mailma Costa de Almeida (22057684)

“…Kaplan-Meier survival analysis evaluated time-to-event outcomes.</p><p>Findings</p><p>Baseline characteristics were comparable across groups. …”

Clinical and epidemiological data of patients. by Mailma Costa de Almeida (22057684)

“…Kaplan-Meier survival analysis evaluated time-to-event outcomes.</p><p>Findings</p><p>Baseline characteristics were comparable across groups. …”

Efficacy primary and secondary outcomes. by Mailma Costa de Almeida (22057684)

“…Kaplan-Meier survival analysis evaluated time-to-event outcomes.</p><p>Findings</p><p>Baseline characteristics were comparable across groups. …”

Summary of correlations in previous studies. by Dan Kuang (136225)

“…</p><p>Conclusions</p><p>This study demonstrates the effectiveness of wastewater surveillance as a long-term sentinel approach for monitoring SARS-CoV-2 and providing early warnings for COVID-19 outbreaks during large international events. This method significantly enhances traditional epidemiological surveillance. …”

The characteristics of nine WWTPs. by Dan Kuang (136225)

“…</p><p>Conclusions</p><p>This study demonstrates the effectiveness of wastewater surveillance as a long-term sentinel approach for monitoring SARS-CoV-2 and providing early warnings for COVID-19 outbreaks during large international events. This method significantly enhances traditional epidemiological surveillance. …”

Data Sheet 1_Disproportionality analysis of adverse events associated with pacritinib: a real-world study based on FDA Adverse Event Reporting System (FAERS) database.docx by Huiling Zhang (396342)

“…The aim of study is provided a comprehensive profile of pacritinib's safety by evaluating the adverse events (AEs) using a real-world pharmacovigilance database.…”

Image 1_Safety assessment of temozolomidee: real-world adverse event analysis from the FAERS database.png by Yu Liu (6938)

“…Renal/metabolic disorders (e.g., hypernatremia) and neurotoxic events (e.g., seizures, ROR 6.19) also demonstrated significant signals.…”

Data Sheet 1_Executive function and neural oscillations in adults with attention-deficit/hyperactivity disorder: a systematic review.pdf by Ziyao Su (14514299)

“…Congruous reduction Pe, P3, and N2 amplitudes during response inhibition tasks, with a further decrease in P3 and N2 amplitudes in sustained attention tasks. …”

Data Sheet 1_Dynamic electrophysiological changes in abnormal brain cavities post-ischemic stroke.docx by Ugur Kilic (9927866)

“…We observed significant decreases in power across different conditions (p < 0.0001), and this decrease varied in different locations. …”

Data Sheet 1_Cognitive component of auditory attention to natural speech events.pdf by Nhan Duc Thanh Nguyen (20506628)

“…Importantly, the component decreases in strength but is still significantly observable in increasingly realistic paradigms of multi-talker environments. …”

Data Sheet 2_The characteristics of auditorial event-related potential under propofol sedation associated with preoperative cognitive performance in glioma patients.docx by Xinxin Wang (134010)

“…Compared to that in the non-MCI group, the average amplitude of the MMN component evoked by the novel stimulus significantly decreased during the recovery period in the MCI group (−3.895 ± 1.961 μV vs. -1.617 ± 1.831 μV, p = 0.003). …”

Data Sheet 1_The characteristics of auditorial event-related potential under propofol sedation associated with preoperative cognitive performance in glioma patients.docx by Xinxin Wang (134010)

“…Compared to that in the non-MCI group, the average amplitude of the MMN component evoked by the novel stimulus significantly decreased during the recovery period in the MCI group (−3.895 ± 1.961 μV vs. -1.617 ± 1.831 μV, p = 0.003). …”

Table 1_The characteristics of auditorial event-related potential under propofol sedation associated with preoperative cognitive performance in glioma patients.docx by Xinxin Wang (134010)

“…Compared to that in the non-MCI group, the average amplitude of the MMN component evoked by the novel stimulus significantly decreased during the recovery period in the MCI group (−3.895 ± 1.961 μV vs. -1.617 ± 1.831 μV, p = 0.003). …”

Data Sheet 3_The characteristics of auditorial event-related potential under propofol sedation associated with preoperative cognitive performance in glioma patients.docx by Xinxin Wang (134010)

“…Compared to that in the non-MCI group, the average amplitude of the MMN component evoked by the novel stimulus significantly decreased during the recovery period in the MCI group (−3.895 ± 1.961 μV vs. -1.617 ± 1.831 μV, p = 0.003). …”

Data Sheet 1_Comparison of adverse events between intensity-modulated radiation therapy and tomotherapy for early stage breast cancer: a retrospective cohort study.pdf by Yan Xia (534241)

“…A comparison of adverse events between the TOMO and IMRT groups showed no significant differences in localized edema, sore throat, tracheal mucositis, nausea, oral mucositis, and the IMRT groups. …”

Table 1_Dividend announcements and share price dynamics: new evidence from Saudi-listed companies using event study approach.docx by Layla Abaalkhail (21583901)

“…Furthermore, results demonstrate that the abnormal return is negative but not significantly different from zero at the time of the announcement of a decrease in the dividend payment level. …”

Image 2_Enhanced cognitive control following neurofeedback therapy in chronic treatment-resistant PTSD among refugees: a feasibility study.tiff by Mirjana Askovic (6562304)

“…Post-treatment, clients were categorised into Responders and Non-Responders, with responders defined as those achieving a clinically significant reduction in PTSD symptoms (≥0.5-point decrease on the HTQ).…”

Image 1_Enhanced cognitive control following neurofeedback therapy in chronic treatment-resistant PTSD among refugees: a feasibility study.tiff by Mirjana Askovic (6562304)

“…Post-treatment, clients were categorised into Responders and Non-Responders, with responders defined as those achieving a clinically significant reduction in PTSD symptoms (≥0.5-point decrease on the HTQ).…”

Table 1_Enhanced cognitive control following neurofeedback therapy in chronic treatment-resistant PTSD among refugees: a feasibility study.pdf by Mirjana Askovic (6562304)

“…Post-treatment, clients were categorised into Responders and Non-Responders, with responders defined as those achieving a clinically significant reduction in PTSD symptoms (≥0.5-point decrease on the HTQ).…”